公开(公告)号：US20240245326A1

公开(公告)日：2024-07-25

申请号：US18624350

申请日：2024-04-02

Applicant: Tandem Diabetes Care, Inc.

Inventor： Michael Blomquist

IPC: A61B5/145 ,  A61B5/00 ,  A61M5/142 ,  A61M5/172 ,  G16H10/20 ,  G16H20/17 ,  G16H40/63 ,  G16H40/67 ,  G16H50/20

CPC classification number: A61B5/14532 ,  A61B5/4839 ,  A61B5/7475 ,  A61M5/1723 ,  G16H10/20 ,  G16H20/17 ,  G16H40/63 ,  G16H40/67 ,  G16H50/20 ,  A61B5/7275 ,  A61B2560/045 ,  A61M2005/14208 ,  A61M2205/3561 ,  A61M2205/52 ,  A61M2230/201

Abstract: An apparatus comprising a pump configured to deliver insulin, an input configured to receive blood glucose data, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a blood glucose data module to compare the blood glucose data to a target blood glucose level for an insulin pump user. The controller is configured to present a question related to the blood glucose level via the user interface when the blood glucose level is different than the target blood glucose level, receive a response to the question via the user interface, and present a recommended user action based at least in part on the response. Other devices, systems, and methods are disclosed.

公开(公告)号：US20240245296A1

公开(公告)日：2024-07-25

申请号：US18429707

申请日：2024-02-01

Applicant: ZOLL Medical Corporation

Inventor： Jason T. Whiting ,  Gary A. Freeman ,  Thomas E. Kaib

IPC: A61B5/00 ,  A61B5/021 ,  A61B5/024 ,  A61B5/11 ,  A61B5/145 ,  A61B5/1455 ,  A61M16/00 ,  A61N1/372 ,  A61N1/39 ,  G06Q50/22 ,  G16H10/60 ,  G16H10/65 ,  G16H20/30 ,  G16H40/67 ,  G16H50/20

CPC classification number: A61B5/0015 ,  A61B5/6805 ,  A61B5/742 ,  A61N1/37247 ,  A61N1/3904 ,  A61N1/39044 ,  A61N1/3925 ,  A61N1/3993 ,  G06Q50/22 ,  G16H10/60 ,  G16H10/65 ,  G16H20/30 ,  G16H40/67 ,  G16H50/20 ,  A61B5/021 ,  A61B5/024 ,  A61B5/11 ,  A61B5/14542 ,  A61B5/14551 ,  A61B5/746 ,  A61M16/0051 ,  A61M16/021 ,  A61M2205/3375 ,  A61M2205/3553 ,  A61M2205/3569 ,  A61M2205/3584 ,  A61M2205/3592 ,  A61M2205/505 ,  A61M2205/52 ,  A61M2209/088 ,  A61M2230/04 ,  A61M2230/06 ,  A61M2230/201 ,  A61M2230/205 ,  A61M2230/30 ,  A61M2230/42 ,  A61M2230/50 ,  A61M2230/63 ,  A61M2230/65

Abstract: A system for managing and distributing patient reports regarding medical devices to end users includes at least one processor configured to perform instructions to receive, from at least one therapeutic medical device, first physiological information relating to at least one therapeutic medical device patient and receive, from at least one monitoring medical device, second physiological information relating to at least one monitoring medical device patient. The at least one processor is also configured to perform instructions to process the first physiological information and the second physiological information, generate a plurality of patient reports from the processed first physiological information and from the processed second physiological information, receive a selection from an end user via an end user terminal, and provide at least one patient report of the plurality of patient reports to the end user terminal based on the received selection.

公开(公告)号：US12042627B2

公开(公告)日：2024-07-23

申请号：US17478530

申请日：2021-09-17

Applicant: Tandem Diabetes Care, Inc.

Inventor： Paul M. DiPerna ,  Michael J. Rosinko ,  Geoffrey A. Kruse ,  Thomas R. Ulrich ,  Christopher Dabrow ,  Mark Williamson ,  Brian Bureson ,  Kathryn Rieger

IPC: A61M5/172 ,  A61M5/14 ,  A61M5/142 ,  A61M5/315 ,  F04B43/113 ,  F04B53/14 ,  F16J15/32 ,  F16J15/56 ,  G16H40/63 ,  A61M5/168 ,  G06F3/0488

CPC classification number: A61M5/172 ,  A61M5/1413 ,  A61M5/14244 ,  A61M5/14248 ,  A61M5/1723 ,  A61M5/31513 ,  F04B43/113 ,  F04B53/143 ,  F16J15/32 ,  F16J15/56 ,  G16H40/63 ,  A61M2005/14268 ,  A61M5/16804 ,  A61M2205/3389 ,  A61M2205/50 ,  A61M2205/505 ,  A61M2205/52 ,  A61M2230/201 ,  A61M2230/63 ,  G06F3/0488

Abstract: Embodiments are directed to portable infusion devices, systems, and methods of using the same for dispensing materials. In some cases, the devices, systems and methods may be used for infusing a material such as medicament, e.g., insulin, into a body in need thereof.

公开(公告)号：US20240238541A1

公开(公告)日：2024-07-18

申请号：US18512906

申请日：2023-11-17

Applicant: Trudell Medical International

Inventor： Adam MEYER ,  Bart NOWAK ,  Ronak SAKARIA ,  Heather YOUNG ,  Cameron ROADHOUSE ,  Michael LAVDAS

IPC: A61M15/00 ,  A61M16/20 ,  A61M16/00

CPC classification number: A61M15/0086 ,  A61M15/009 ,  A61M16/202 ,  A61M2016/0024 ,  A61M2016/0033 ,  A61M2205/0272 ,  A61M2205/331 ,  A61M2205/3375 ,  A61M2205/3584 ,  A61M2205/3592 ,  A61M2205/52

Abstract: A medication delivery system including a holding chamber having an input and an output end, a backpiece coupled to the input end of the holding chamber and having an electrical circuit and an opening. An MDI includes an insert portion moveable between an engaged position wherein the insert portion is received in the opening and a disengaged position wherein the insert portion is removed from the opening, and at least one contact that completes the electrical circuit when the insert portion is in the engaged position.

公开(公告)号：US12036389B2

公开(公告)日：2024-07-16

申请号：US17142425

申请日：2021-01-06

Applicant: Insulet Corporation

Inventor： Joon Bok Lee ,  Yibin Zheng ,  Jason O'Connor

IPC: A61M5/172 ,  A61M5/142

CPC classification number: A61M5/1723 ,  A61M5/14244 ,  A61M2205/52 ,  A61M2230/201

Abstract: Exemplary embodiments provide an approach to predicting meal and/or exercise events for an insulin delivery system that otherwise does not otherwise identify such events. The insulin delivery system may use a model of glucose insulin interactions that projects estimated future glucose values based on a history of glucose values and insulin deliveries for a user. The predictions of meal events and/or exercise events may be based on residuals between actual glucose values and predicted glucose values. The exemplary embodiments may calculate a rate of change of the residuals over a period of time and compare the rate of change to thresholds to determine whether there likely has been a meal event or an exercise event. The insulin delivery system may then take measures to account for the meal event or the exercise event by the user.

公开(公告)号：US12036361B2

公开(公告)日：2024-07-16

申请号：US17494551

申请日：2021-10-05

Applicant: Freelander Innovations USA, LLC

Inventor： Michael Freelander

IPC: A61M15/06 ,  A24F40/30 ,  A24F40/40 ,  A24F40/50 ,  A24F40/60 ,  A61M11/04 ,  A61M15/00 ,  A24F40/20 ,  A61M16/00

CPC classification number: A61M15/06 ,  A24F40/30 ,  A24F40/40 ,  A24F40/50 ,  A24F40/60 ,  A61M11/042 ,  A61M15/0023 ,  A61M15/0051 ,  A61M15/008 ,  A24F40/20 ,  A61M2016/0021 ,  A61M2205/3306 ,  A61M2205/3334 ,  A61M2205/3368 ,  A61M2205/3553 ,  A61M2205/3569 ,  A61M2205/3584 ,  A61M2205/3592 ,  A61M2205/3653 ,  A61M2205/368 ,  A61M2205/505 ,  A61M2205/52 ,  A61M2205/8206 ,  A61M2209/06

Abstract: A method for controlling a vaporizer device may include determining a first temperature, vaporizing an inhalable substance at the first temperature, raising the first temperature by a temperature quantity, wherein a second temperature is a sum of the temperature quantity and the first temperature; and vaporizing the inhalable substance at the second temperature, wherein the temperature quantity is less than 3° C.

公开(公告)号：US20240226475A1

公开(公告)日：2024-07-11

申请号：US18535560

申请日：2023-12-11

Applicant: ZOLL Medical Corporation

Inventor： Annemarie E. Silver ,  Frederick J. Geheb ,  Gary L. Hochstettler ,  Vladimir Floroff ,  Gary A. Freeman

IPC: A61M16/00 ,  A61B5/00 ,  A61B5/087 ,  A61M16/06 ,  A61N1/39

CPC classification number: A61M16/0078 ,  A61B5/087 ,  A61B5/747 ,  A61M16/0003 ,  A61M16/0084 ,  A61M16/021 ,  A61M16/06 ,  A61N1/3925 ,  A61B5/002 ,  A61B5/0022 ,  A61M2016/003 ,  A61M2016/0036 ,  A61M2202/0208 ,  A61M2205/3553 ,  A61M2205/3592 ,  A61M2205/50 ,  A61M2205/505 ,  A61M2205/52 ,  A61M2205/581 ,  A61M2205/583 ,  A61M2205/584 ,  A61M2230/005 ,  A61M2230/04 ,  A61M2230/06 ,  A61M2230/205 ,  A61M2230/432 ,  A61M2230/435 ,  A61N1/3993

Abstract: A medical ventilation monitoring system is provided. The system includes: a patient ventilation unit defining an airflow path, and arranged so that when the unit is applied to a patient, the airflow path is in fluid communication with the patient's airway. The patient ventilation unit includes: an airflow sensor positioned to sense the presence of ventilation airflow to or from the patient and a communication link. The system also includes at least one processor arranged to communicate with the ventilation unit by the communication link. The at least one processor is configured to: provide an initial treatment protocol for providing care to the patient, receive data regarding a current condition of the patient from the ventilation unit, and determine an updated treatment protocol. The updated treatment protocol includes applying ventilation at an updated ventilation volume or at an updated ventilation rate based on information from the airflow sensor.

公开(公告)号：US20240226464A1

公开(公告)日：2024-07-11

申请号：US17763585

申请日：2020-09-24

Applicant: JANSSEN PHARMACEUTICALS, INC.

Inventor： Francesco N. ALBERTINI ,  Gregory J. BAKOS ,  Michael A. BARATTA ,  Michael CANNAMELA ,  Anthony R. DIUBALDI ,  Yueheng DOU ,  Wayne DREVETS ,  James A. FLEMING ,  Jason L. HARRIS ,  Kevin L. HOUSER ,  Emma Louise HUBERT ,  Michael HUTCHINSON ,  Monica A. KAPIL ,  Peter KRULEVITCH ,  Chaley John LARSON ,  Wouter Jacques Noel LEQUIEU ,  Kui LIU, IV ,  Frederick E. SHELTON, IV ,  George SZABO ,  Steven M. VESOLE ,  Jingli WANG ,  Hong YAN

IPC: A61M15/00 ,  G06T7/00

CPC classification number: A61M15/0003 ,  A61M15/0066 ,  G06T7/00 ,  A61M2205/52 ,  A61M2230/201 ,  A61M2230/30 ,  A61M2230/50

Abstract: Provided herein are drug administration devices, methods, and systems for adjusting drug delivery to a patient to allow drug dosage to be adjusted based on a variety of different factors influencing the patient during administration of the drug. In one embodiment, a drug administration device or system can have a drug holder with a drug therein to be delivered to a patient, one or more sensors that are configured to gather various data associated with the patient, and at least one processor that can analyze the data gathered by the one or more sensors and adjust delivery of the drug based on the data.

公开(公告)号：US12029913B2

公开(公告)日：2024-07-09

申请号：US16969560

申请日：2019-08-13

Applicant: INTIN CO., LTD.

Inventor： Ji Hoon Kim

IPC: A61N5/06 ,  A61M1/00 ,  A61M11/00 ,  A61M11/02 ,  A61M15/00 ,  A61M16/00 ,  A61N5/067

CPC classification number: A61N5/0603 ,  A61M1/76 ,  A61M1/84 ,  A61M11/005 ,  A61M11/02 ,  A61M15/0085 ,  A61M16/0063 ,  A61M16/022 ,  A61M2205/051 ,  A61M2205/3576 ,  A61M2205/52 ,  A61M2205/583 ,  A61N2005/0604 ,  A61N2005/0605 ,  A61N2005/0607 ,  A61N2005/0626 ,  A61N2005/0644 ,  A61N2005/0651 ,  A61N5/067

Abstract: The present invention provides a synthetic treatment apparatus which comprises: a connection part in which treatment part modules are replaced and are connected to or separated from each other, the treatment part modules performing inhalation, suction, light emitting, and aerosol functions, respectively, which are required for treatment for a respiratory disease and ear disease; a power part for supplying power to the treatment part modules according to an operation of a power switch; and a control part for controlling the power module and functions of the treatment part modules, wherein a grip part is formed on the outside of a body in which the power part and the control part are embedded. The present invention can treat various ear and respiratory diseases by replacing a head of the apparatus.

公开(公告)号：US12029881B2

公开(公告)日：2024-07-09

申请号：US17991933

申请日：2022-11-22

Applicant: DEKA Products Limited Partnership

Inventor： Dean Kamen ,  John M. Kerwin ,  Colin H. Murphy ,  Jonathan Parker ,  Daniel F. Pawlowski ,  Dirk A. van der Merwe ,  Larry B. Gray ,  Christopher C. Langenfeld ,  Michael S. Place ,  Michael J. Slate

IPC: A61M5/168 ,  A61M5/14 ,  G16H20/17 ,  A61M5/142 ,  A61M5/145 ,  F04B43/08 ,  F04B43/12 ,  G16H40/67

CPC classification number: A61M5/16859 ,  A61M5/1411 ,  A61M5/16827 ,  A61M5/16831 ,  A61M5/1689 ,  G16H20/17 ,  A61M5/1415 ,  A61M5/1417 ,  A61M5/14216 ,  A61M5/14224 ,  A61M5/14228 ,  A61M5/1452 ,  A61M5/1456 ,  A61M5/1458 ,  A61M2005/16863 ,  A61M2005/16868 ,  A61M2205/12 ,  A61M2205/14 ,  A61M2205/18 ,  A61M2205/3306 ,  A61M2205/3317 ,  A61M2205/332 ,  A61M2205/3375 ,  A61M2205/3576 ,  A61M2205/50 ,  A61M2205/505 ,  A61M2205/52 ,  A61M2209/082 ,  A61M2209/086 ,  F04B43/08 ,  F04B43/082 ,  F04B43/1223 ,  G16H40/67

Abstract: A pump for pumping fluid includes a tube platen, a plunger, a bias member, inlet and outlet valves, an actuator mechanism, a position sensor, and a processor. The plunger is configured for actuation toward and away from the infusion-tube when the tube platen is disposed opposite to the plunger. The tube platen can hold an intravenous infusion tube. The bias member is configured to urge the plunger toward the tube platen.